Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Sari Pediatri Majalah Patologi Indonesia Jurnal Penyakit Dalam Indonesia
Atmakusuma, Tubagus Djumhana
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Five Year Survival of Active Multiple Myeloma Patients Based on Durie-Salmon and International Myeloma Working Group 2003 Diagnostic Criteria Kurniawati, Sri Agustini; Reksodiputro, Ary Harryanto; Atmakusuma, Tubagus Djumhana
Jurnal Penyakit Dalam Indonesia Vol. 7, No. 3
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Introduction. Survival of active multiple myeloma (MM) patients is determined by early diagnosis and various prognostic factors. The development of MM diagnostic criteria from Durie-Salmon (DS) criteria to International Myeloma Working Group (IMWG) 2003 is an attempt to diagnose active MM earlier. However, due to limited resources, these diagnostic criteria cannot be fulfilled consistently in Indonesia. Based on this reason, it is necessary to know the proportion of MM based on DS and IMWG 2003 diagnostic criteria and also their impact on the survival of MM patients in Indonesia. Methods. This was a retrospective cohort study with survival analysis. Subjects were active MM patients in Cipto Mangunkusumo Hospital and Dharmais Cancer Hospital during 2005-2015. Data were presented in Kaplan-Meier survival curve and table with 95% confidence interval (CI). Results. This study involved 102 active MM patients with complete diagnostic data and survival for more than 1 month. As much as 56.9% of patients met DS diagnostic criteria and 72.5% met IMWG 2003 criteria. Median of overall survival (OS) based on DS criteria (77.8 months) was similar with IMWG 2003 criteria. Overall survival in the first, third, and fifth year of MM patients who met DS criteria were 89.9%, 77.5%, and 54.8%, respectively. Meanwhile overall survival in the first, third, and fifth year of MM patients who met IMWG 2003 criteria were 87.5%, 75.6% and 55.9%, respectively. Conclusions. The proportion of active MM patients who met IMWG 2003 diagnostic criteria was higher than those who met DS criteria. Overall survival of active MM patients who meet DS diagnostic criteria is similar with those who met IMWG 2003 criteria.
Pengetahuan Tenaga Kesehatan Mengenai Diagnosis dan Tata Laksana Hemofilia: Studi Analisis Pra-Pasca Sesi Edukasi pada Delapan Provinsi di Indonesia Chozie, Novie Amelia; Primacakti, Fitri; Sarita, Raisa Cecilia; Gatot, Djajadiman; Abigail, Dina Clarisa Rumora; Atmakusuma, Tubagus Djumhana
Sari Pediatri Vol 27, No 3 (2025)
Publisher : Badan Penerbit Ikatan Dokter Anak Indonesia (BP-IDAI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14238/sp27.3.2025.187-92

Abstract

Latar belakang. Tingkat pengetahuan tenaga kesehatan (nakes) memiliki peranan penting dalam diagnosis dan penanganan hemofilia, terutama dokter umum sebagai tenaga kesehatan lini pertama. Maka dari itu, kami mengadakan sesi edukasi untuk nakes mengenai manajemen dan diagnosis hemofilia. Tujuan. Studi ini bertujuan untuk menganalisis dampak sesi edukasi bagi pengetahuan nakes terhadap diagnosis dan tata laksana hemofilia di delapan provinsi di Indonesia.Metode. Studi ini menggunakan desain potong-lintang, deskriptif, analisis data sekunder dari kuesioner terstruktur, yang diisi secara mandiri sebelum (pra) dan sesudah (pasca) sesi edukasi, berisikan pilihan ganda berjumlah 8 soal berkaitan dengan pengetahuan dasar hemofilia untuk menemukan dampak sesi edukasi. Analisis data menggunakan Tes Wilcoxon.Hasil. Total partisipan sesi edukasi berjumlah 1231 dengan 983 mengisi data diri lengkap dan 565 memenuhi kriteria inklusi. Mayoritas dari partisipan yang memenuhi kriteria adalah dokter umum (46,7%) diikuti dokter anak (9,2%), dan dokter penyakit dalam (3,4%). Hasil tes pra dan pasca sesi edukasi dilakukan analisis. Skor median untuk tes pra-sesi adalah 5 (0-8) dan pasca-sesi adalah 7 (3-8). Hasil dari Tes Wilcoxon didapatkan p<0,0001.Kesimpulan. Perbaikan skor setelah sesi edukasi menunjukkan peningkatan pengetahuan yang signifikan pada nakes mengenai hemofilia, yang dapat berkontribusi pada diagnosis dan tata laksana hemofilia di Indonesia.
Ekspresi Topoisomerase II α pada Diffuse Large B Cell Lympho-ma dan Hubungannya dengan Respon Terapi Windarti, Indri; Hardjolukito, Endang SR; Ham, Maria Francisca; Atmakusuma, Tubagus Djumhana; Rajabto, Wulyo
Majalah Patologi Indonesia Vol. 22 No. 3, September 2013
Publisher : Perhimpunan Dokter Spesialis Patologi Anatomik Indonesia (PDSPA)

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

ABSTRAK Latar belakang Kemoterapi pilihan untuk Diffuse Large B Cell Lymphoma (DLBCL) adalah regimen yang mengandung doksorubisin. Doksorubisin merupakan obat kemoterapi golongan antrasiklin yang bekerja sebagai anti Topoisomerase II (Top2). Penelitian sebelumnya terhadap galur sel tumor menunjukkan bahwa ekspresi Topoisomerase II α (Top2A) yang tinggi berhubungan dengan sensitifitas terhadap antrasiklin yang tinggi pula. Tujuan penelitian ini adalah untuk mengetahui ekspresi protein Top2A pada DLBCL dan hubungannya dengan respon terapi. Metode Studi potong lintang dilakukan terhadap 38 kasus DLBCL dengan pulasan CD20 positif, yang telah mendapat kemoterapi minimal 4 siklus. Imunohistokimia dilakukan pulasan terhadap protein Top2A dengan menggunakan H-score. Hasil Ekspresi Top2A ditemukan pada 37 dari 38 kasus (97%) dengan kisaran H-score 101,5-215,0 dan median 124,1. H-score nilai Top2A dikatakan tinggi jika H-score lebih dari 124,1. Analisis statistik menunjukkan bahwa ekspresi Top2A pada DLBCL tidak berhubungan bermakna dengan respon terapi (p=0,670). Kesimpulan Ekspresi Top2A dan respon terapi tidak memiliki hubungan bermakna. Ekpresi Top2A pada DLBCL tidak dapat dijadikan prediktor respon terapi. Kata kunci: DLBCL, Doksorubisin, ekspresi Top2A, respon terapi. ABSTRACT Background Standard of chemotherapy for Diffuse Large B Cell Lymphoma (DLBCL) is a regimen containing doxorubicin. Doxorubicin is a component of anthracycline based chemotherapy that work as anti Topoisomerase II (Top2). Previous study on tumor cell lines showed that high expression of Topoisomerase II α (Top2A) was related to higher sensitivity to anthracycline as well. The aim of this study is to know the expression of Top2A and its relation to treatment response. Methods A cross-sectional study on 38 which DLBCL cases CD20 positive that have been treated with at least 4 cycles of chemotherapy. The immunohistochemical staining was performed on Top2A protein assesed using H-score. Results Expression of Top2A protein were found in 37 of 38 (97%) cases (H-score range: 101.5-215.0 and median 124.1). Value Top2A was defined as high if H-score more was higher than 124.1. Statistical analysis showed that Top2A expression in DLBCL was not significantly related to treatment response (p=0.670). Conclusion There was no significant relation between Top2A expression and treatment response. Top2A expression in DLBCL cannot be used as a predictor of treatment response. Key words: DLBCL, Doxorubicin, Top2A expression, treatment response.
Co-Authors Abigail, Dina Clarisa Rumora Djajadiman Gatot Fitri Primacakti, Fitri Ham, Maria Francisca Hardjolukito, Endang SR Indri Windarti Novie Amelia Chozie Reksodiputro, Ary Harryanto Sarita, Raisa Cecilia Sri Agustini Kurniawati, Sri Agustini Wulyo Rajabto